Cantargia partners with BioInvent International for CAN10 manufacturing contract

Sweden-based biopharmaceutical company Cantargia has entered a significant partnership with BioInvent International to advance the manufacturing of CAN10, a monoclonal antibody currently in preclinical development ... Read More